{
    "title": "EU regulators approve GSK's bone cancer drug momelotinib",
    "url": "https://www.dailymail.co.uk/money/markets/article-12744715/EU-regulators-approve-GSKs-bone-cancer-drug-momelotinib.html",
    "date": "2023-11-13",
    "keywords": [
        "bone",
        "marrow",
        "cancer",
        "share",
        "account",
        "fund",
        "shot",
        "arm",
        "gsk",
        "treatment",
        "momelotinib",
        "risk",
        "year",
        "month",
        "vaccine",
        "rsv",
        "money",
        "diy",
        "investment",
        "fee",
        "type",
        "group",
        "executive",
        "emma",
        "boost",
        "committee",
        "agency",
        "drug",
        "use",
        "union",
        "myelofibrosis",
        "body",
        "blood",
        "illness",
        "anaemia",
        "weakness",
        "fatigue",
        "damage",
        "decision",
        "recommendation",
        "walmsley",
        "business",
        "blockbuster",
        "ftse",
        "firm",
        "profit",
        "guidance",
        "time",
        "breakthrough",
        "respiratory",
        "arexvy",
        "virus",
        "fact",
        "pharmacy",
        "chain",
        "cvs",
        "ryanairs",
        "michael",
        "race",
        "brummer",
        "bae",
        "invasion",
        "war",
        "crime",
        "wave",
        "street",
        "article",
        "capital",
        "isa",
        "trade",
        "community",
        "model",
        "affiliate",
        "product",
        "commission",
        "editorial",
        "independence",
        "investing",
        "platform"
    ],
    "category": [
        "money",
        "markets"
    ]
}